The largest database of trusted experimental protocols

2 protocols using α cd3 apc

1

RIPK1 Kinase Inhibitor Mechanism Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The GSK’963 RIPK1 kinase inhibitor was provided by GSK. The following antibodies were used: α-RIPK1 (BD Biosciences, 610459), α-HOIL (gift from Henning Walczak), α-cIAP1 (Enzo, ALX-803-335-C100), α-TNFR1 (Abcam, 19139), α-Actin (Santa Cruz Biotechnology, sc-1615), α-P-p65 (Cell Signaling, 3033), α-p65 (Cell Signaling, 8242), α-IkBα (Santa Cruz, sc-371), α-P-p38 (Cell Signaling, 9215), α-p38 (Cell Signaling, 9212), α-P-JNK (Cell Signaling, 9255), α-JNK (Santa Cruz Biotechnology, sc-571), α-P-ERK (Cell Signaling, 9101), α-ERK (gift from Chris Marshall) α-caspase-8 (Cell Signaling, 9429), α-FLAG [M2] (SIGMA, M8823), α-Ub (Dako, Z0458), α-FLIP (Adipogene, AG-20B-0056), α-FADD (Santa Cruz Biotechnology, sc-6036), α-RIPK3 (ProSci, 2283), α-Tubulin (SIGMA, T9026), α-SHARPIN (Proteintech, 14626-1-AP), α-TRAF2 (Cell Signaling, 4712), α-CD8-PE-Cy7, GR-1-PE-Cy7, CD11c-FITC, CD4-FITC, CD11b-Cy5, B220-FITC (gift from Henning Walczak), α-CD69-PE (eBioscience, 12-0691-82), α-CD3-APC (eBioscience, 47-0032-82), and α-CD16 (eBioscience, 14-0161-82).
+ Open protocol
+ Expand
2

T Cell Activation Assay with DC Presentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the T cell activation assay, HLA-A2 positive human DCs were adhered for 1 h at 37 °C in X-vivo medium (Lonza) containing 2% human serum in 96 wells plates. Cells were then washed and incubated with gp100 short (10 μM gp100 (residues 280–288); GenScript) or long (100 μM gp100 (residues 272–300); JPT) peptide with T cell receptor stimulation mix (4 μg/ml R-848 and poly(I:C); Enzo Life Sciences) for 4 h. After incubation, cells were washed and resuspended in X-vivo medium containing Jurkat E6.1 cells (ratio 1 DC: 2 T cells) and co-cultured for 18 h at 37 °C. T cells were stained with αCD69-FITC (1:10; BD biosciences), αCD3-APC (1:10; eBiosciences) and Propidium Iodide (PI; 0.5 μg/ml) and analyzed with a FACS Calibur (BD biosciences). CD69 surface levels as a measure of T cell activation were analyzed using FlowJo software and Prism 5. Briefly, cells were gated on viability (PI), followed by gating for CD3-positive cells, and the CD69 signals were determined. T cell activation was calculated as the ratio of CD69 positive cells stimulated with long over stimulation with short peptide.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!